Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?

BACKGROUND: Switching to aripiprazole from other antipsychotics can avoid antipsychotic-induced hyperprolactinemia but may result in an abnormally low prolactin level. This study aimed to assess whether the aripiprazole-induced abnormally low prolactin level was a biomarker for subsequent rebound of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jen, Ya-Wen, Hwang, Tzung-Jeng, Chan, Hung-Yu, Hsieh, Ming H., Liu, Chen-Chung, Liu, Chih-Min, Hwu, Hai-Gwo, Kuo, Ching-Hua, Lin, Yi-Ting, Chien, Yi-Ling, Chen, Wei J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686669/
https://www.ncbi.nlm.nih.gov/pubmed/33228575
http://dx.doi.org/10.1186/s12888-020-02957-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686669/
https://www.ncbi.nlm.nih.gov/pubmed/33228575
http://dx.doi.org/10.1186/s12888-020-02957-7

Ejemplares similares